Vital Infrastructure: From European Exit to North American Rebuild

Vital Infrastructure Property Trust’s second-quarter 2026 results confirm that the transformation story is not just rhetoric. CEO Zachary Vaughan, in his fourth earnings call since taking over, opened with a clear statement: “We are still in the early stages of this transformation, but we are making strong progress across each of these priorities as demonstrated by our results this quarter.” That progress is visible in nearly every metric the company controls, from leverage to G&A to the speed of capital recycling.

A Pivot to North America

The European portfolio sale was the headline event of the quarter, generating $145 million in net proceeds. With the transfer of the operating business and employees to TPG, the company has effectively exited Europe, leaving only two small investments it plans to exit “in due course.” The proceeds are already being redeployed across the Atlantic—most notably into the New York market, where Vital acquired the East New York Health Hub in Brooklyn. That 142,000-square-foot, transit-connected outpatient center is 100% leased to Advantage Care Physicians, a large multi-specialty group, and carries a 11-year lease with escalators. It’s a textbook example of the company’s new focus on high-quality, long-duration healthcare real estate in dense urban markets.

CEO Zachary Vaughan admits the pipeline is “skewed about two-thirds to the U.S.,” reflecting the reality that “a lot of the health care assets and infrastructure is sort of single payer owned” in Canada. This is a deliberate strategic choice, not an accident. Combined with a committed acquisition in Burlington, Ontario, the company has now committed roughly $153 million of North American acquisitions at a blended cap rate of over 7%. As Vaughan puts it, “we have demonstrated that we are able to reinvest that cash capital into opportunities that are accretive for our unitholders.”

Balance Sheet and Costs Make Progress

The financial results underscore the discipline. Proportionate leverage fell to 46.8% from 52.7% in the prior quarter, and debt-to-adjusted EBITDA improved to 7.1x (7.7x on a comparable basis). CFO Stephanie Karamarkovic reiterated a mid-term target of “around that 50% or 8x debt to EBITDA” and emphasized the growing pool of unencumbered assets, which gives the company more financing options. G&A decreased by $2.2 million year-over-year, and headcount is down nearly 40% from a year ago, putting the company on track to reach an annualized run-rate of $35 million (excluding unit-based compensation and severance) by year-end. The primary care push in Canada, with governments funding new family health teams, also provides a tailwind for occupancy and demand.

In the past 12 months, we have realized approximately $300 million of net proceeds that have been recycled back to North America through a combination of debt reduction and accretive investments.

The company also closed the quarter with occupancy at 96.1% and a weighted average lease term of over 13 years, one of the longest in the Canadian REIT universe. Same-property NOI grew 3.2% (excluding a one-time facilities outsourcing step-up), driven by contractual escalations and parking income. The CFO noted that AFFO per unit rose to $0.11 from $0.10 sequentially, and the payout ratio improved to 85% from 88% a year ago.

Healthscope: A Catalyst Still in Motion

The one major overhang—Australia’s Healthscope—remains unresolved, but there are encouraging signs. A consortium of four operators is in active diligence with the receiver, and Vital has a committed transaction with Calvary, a high-quality not-for-profit operator, to take over all 12 properties, subject to lender and receiver approval. While terms are not yet disclosed, the company expects an update before Q3. CEO Zachary Vaughan noted that Melbourne hospital asset sales are trading at “low-5% cap rates,” an indication that institutional capital is returning to Australian healthcare. The recent refinancing of AUD $715 million in JV debt, extended out to December 2028, also demonstrates that lenders are seeing the asset class more favorably.

Looking ahead, the company has multiple levers for value creation. The convertible debentures issue is being actively managed—$2.9 million was repurchased year-to-date, and the Series H debentures become callable on September 1, allowing the company to revisit the most efficient way to address the maturity. The portfolio sale proceeds have been redeployed, but the company retains flexibility through its remaining European investments, its stake in New Zealand Vital Trust (now unencumbered), and the potential for further Australian disposals as Healthscope resolves. The Fairview Health Centre rezoning—980,000 square feet of buildable area, including 100,000 square feet of medical space—offers significant development optionality, with the balance likely residential.

Vital Infrastructure is no longer just a real estate owner; it is a focused North American healthcare infrastructure platform. The transformation is still early, but the trajectory is clear. As Vaughan summarizes, “Vital is becoming a simpler, a stronger and a more focused company.” With a cleaner balance sheet, a lower cost base, and a pipeline of accretive opportunities, the payoff could be substantial for unitholders.